Lutathera (lutetium Lu 177 dotatate) - Novartis
Evaluation of Time-Point Selection Using a Prior-Information Approach for Single-Time-Point Dosimetry in 177 Lu-DOTATATE Therapy (EANM 2026) - Sep 29, 2026 - Abstract #OP-642; Pres time: Oct 20, 2026; 09:45 AM - 11:15 AM; Location: Hall K; "The prior-information approach enabled accurate estimation of absorbed doses compared with the conventional multi-time-point dosimetry. These findings suggest that the number of required imaging time points for dosimetry in subsequent treatment cycles might be reduced." 
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
A. Komatsu 1; N. Miyaji 1; T. Yamao 1; K. Wachi 1; N. Akiya 1; M. Masubuchi 1, 2; T. Horikawa 1; Y. Ogane 1; O. Kanno 1; S. Mashiko 1; A. Oishi 3; M. Morimoto 3; Y. Yamamoto 4; Y. Nishiyama 4; K. Miwa 1
 
Sep 29, 2026
 
Prev Next